Berry Genomics Co Ltd (000710) — Cash Flow-to-Debt Ratio
Berry Genomics Co Ltd (000710) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-2.18 Million could theoretically repay 0% of its total liabilities (CN¥694.43 Million) in one year. Explore long-term investment intensity of Berry Genomics Co Ltd to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Berry Genomics Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Berry Genomics Co Ltd across 27 annual periods. Also explore total assets of Berry Genomics Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Berry Genomics Co Ltd (1998–2024)
Year-by-year debt coverage analysis for Berry Genomics Co Ltd. For market capitalisation and broader financial context, see Berry Genomics Co Ltd (000710) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | CN¥87.97 Million | CN¥669.56 Million | ▲ +0.2% |
| 2023 | 0.13x | CN¥111.01 Million | CN¥846.56 Million | ▲ +439.6% |
| 2022 | 0.02x | CN¥21.18 Million | CN¥871.54 Million | ▼ -74.3% |
| 2021 | 0.09x | CN¥94.03 Million | CN¥996.02 Million | ▼ -51.9% |
| 2020 | 0.20x | CN¥161.31 Million | CN¥821.52 Million | ▲ +15.2% |
| 2019 | 0.17x | CN¥123.06 Million | CN¥721.83 Million | ▼ -75.7% |
| 2018 | 0.70x | CN¥165.33 Million | CN¥235.68 Million | ▲ +132.0% |
| 2017 | 0.30x | CN¥74.35 Million | CN¥245.94 Million | ▲ +1024.5% |
| 2016 | -0.03x | CN¥-14.19 Million | CN¥433.97 Million | ▲ +82.4% |
| 2015 | -0.19x | CN¥-70.81 Million | CN¥381.19 Million | ▼ -410.2% |
| 2014 | 0.06x | CN¥18.91 Million | CN¥315.83 Million | ▲ +10.8% |
| 2013 | 0.05x | CN¥15.63 Million | CN¥289.09 Million | ▼ -75.7% |
| 2012 | 0.22x | CN¥48.27 Million | CN¥217.34 Million | ▲ +340.9% |
| 2011 | -0.09x | CN¥-21.46 Million | CN¥232.73 Million | ▼ -131.6% |
| 2010 | 0.29x | CN¥76.19 Million | CN¥261.04 Million | ▲ +3252.5% |
| 2009 | -0.01x | CN¥-2.33 Million | CN¥251.54 Million | ▼ -103.3% |
| 2008 | 0.28x | CN¥57.76 Million | CN¥206.93 Million | ▲ +680.6% |
| 2007 | 0.04x | CN¥4.70 Million | CN¥131.54 Million | ▼ -55.6% |
| 2006 | 0.08x | CN¥11.68 Million | CN¥144.87 Million | ▲ +43.8% |
| 2005 | 0.06x | CN¥7.58 Million | CN¥135.26 Million | ▲ +244.6% |
| 2004 | -0.04x | CN¥-6.43 Million | CN¥165.77 Million | ▼ -361.6% |
| 2003 | -0.01x | CN¥-1.23 Million | CN¥146.30 Million | ▼ -107.5% |
| 2002 | 0.11x | CN¥14.91 Million | CN¥133.22 Million | ▲ +125.7% |
| 2001 | -0.44x | CN¥-85.39 Million | CN¥195.81 Million | ▼ -565.4% |
| 2000 | -0.07x | CN¥-8.21 Million | CN¥125.33 Million | ▼ -133.3% |
| 1999 | 0.20x | CN¥15.30 Million | CN¥77.77 Million | ▼ -33.0% |
| 1998 | 0.29x | CN¥28.30 Million | CN¥96.34 Million | — |